Title : BKM120 sensitizes C6 glioma cells to temozolomide via suppression of the PI3K/Akt/NF-κB/MGMT signaling pathway.

Pub. Date : 2017 Dec

PMID : 29151909






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 BKM120 sensitizes C6 glioma cells to temozolomide via suppression of the PI3K/Akt/NF-kappaB/MGMT signaling pathway. NVP-BKM120 nuclear factor kappa B subunit 1 Homo sapiens
2 However, a low concentration of BKM120 inhibited the PI3K/Akt/NF-kappaB signaling pathway activity in glioma cells and significantly increased TMZ cytotoxicity. NVP-BKM120 nuclear factor kappa B subunit 1 Homo sapiens
3 The reduction of NF-kappaB p65 in combination treatment supported the hypothesis that BKM120 may mediate MGMT transcription via inhibition of NF-kappaB p65. NVP-BKM120 nuclear factor kappa B subunit 1 Homo sapiens
4 The reduction of NF-kappaB p65 in combination treatment supported the hypothesis that BKM120 may mediate MGMT transcription via inhibition of NF-kappaB p65. NVP-BKM120 nuclear factor kappa B subunit 1 Homo sapiens
5 The BKM120-induced NF-kappaB p65 inhibition may be involved in the mediation of MGMT transcription to reverse TMZ-resistance in C6 glioma cells. NVP-BKM120 nuclear factor kappa B subunit 1 Homo sapiens